Discover Startups Pear TherapeuticsPear Therapeutics Funding Rounds, Valuation & Investors

Pear Therapeutics

Creating a better world by pioneering software as treatment for serious disease201-500 Employees

B2B
Public Stage
Publicly traded company
4.4
Work / Life Balance
Employees rate Pear Therapeutics 4.4/5 on Glassdoor for work / life balance
4.5
Strong Leadership
Employees rate Pear Therapeutics 4.5/5 on Glassdoor for faith in leadership

Pear Therapeutics Funding

$0

66 rounds

Pear Therapeutics is active in the following markets / industries: biotechnology, health care information technology, big data, therapeutics, application platforms, mobile games, mhealth and mobile application. The company has secured funding across 6 rounds and is valued at $0. Their most recent funding was raised on December 6, 2021.

Funding Rounds

SP

$175000000

SPACDec 2021$0 valuation

Press

Pear Therapeutics and Thimble Point Announce Closing of Business Combination to Create Publicly Traded Prescription Digital Therapeutics Company - Pear Therapeutics

D

$80000000

Series DDec 2020$0 valuationRead press

+4

C

$64000000

Series CJan 2019$0 valuation

+1

B

$50000000

Series BNov 2017$0 valuation

+1

U

$20000000

UnknownFeb 2016$0 valuationRead press

U

Undisclosed amount

UnknownMar 2015$0 valuation

Investors of Pear Therapeutics

Novartis International AG Group

VC Firm

Rounds

D

CrimsoNox Capital

VC Firm

Rounds

D

EDBI

VC Firm • Singapore

Rounds

D

SoftBank Capital

VC Firm • New York City

Multi-stage $600M venture fund delivering strategic value to founders since 1995

Rounds

D

Novartis Venture Fund

VC Firm • Basel

Rounds

C

B

Temasek

VC Firm • Singapore

Rounds

D

C

B

JAZZ Venture Partners

VC Firm • Silicon Valley

Rounds

D

C

B

U

Arboretum Ventures

VC Firm • Ann Arbor

Rounds

D

C

B

U

5AM Ventures

VC Firm

Rounds

D

C

B

U

U

Back to People

Onwards to Jobs